Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 27 Jan 2023 for Metacrine, Inc., €41k. Read the official filing
Filing timeline
BuySaleMichael York
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Michael York: trading record in brief
Filings by Michael York span 2 companies, the busiest being Metacrine, Inc. and PhaseBio Pharmaceuticals Inc. We count 3 filings; the first trade dates from 20 May 2021 and the latest from 26 January 2023.
Every open-market trade on record is a sale: 1 sale worth €41k. Other entries cover 2 share grants. In 2023 alone, the filings show no purchases and 1 sale.
Most recently, on 27 January 2023, the filings show an open-market sale worth €41k in Metacrine, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Michael York
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
107,054 shares@ US$0.4141100.0% of flowCommon StockSEC:0001209191-23-005275:0
210,553 shares0Common StockSEC:0001209191-22-014077:0
2,897 shares@ US$2.80100.0% of flowCommon StockSEC:0001169245-21-000044:0
3 of 3 declarations
